|
TMEM206 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.195670E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.036190E-02 |
| Normal-vs-Stage2 |
2.399000E-01 |
| Normal-vs-Stage3 |
7.804200E-02 |
| Normal-vs-Stage4 |
5.808000E-02 |
| Stage1-vs-Stage2 |
4.374800E-01 |
| Stage1-vs-Stage3 |
6.506600E-01 |
| Stage1-vs-Stage4 |
6.847200E-01 |
| Stage2-vs-Stage3 |
7.101800E-01 |
| Stage2-vs-Stage4 |
3.741000E-01 |
| Stage3-vs-Stage4 |
5.057400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.702240E-02 |
| Normal-vs-AfricanAmerican |
4.367600E-01 |
| Normal-vs-Asian |
1.689230E-01 |
| Caucasian-vs-AfricanAmerican |
8.335800E-01 |
| Caucasian-vs-Asian |
5.492400E-01 |
| AfricanAmerican-vs-Asian |
9.520600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.280420E-02 |
| Normal-vs-Female |
2.455500E-02 |
| Male-vs-Female |
3.907000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.717890E-02 |
| Normal-vs-Age(41-60Yrs) |
1.813390E-01 |
| Normal-vs-Age(61-80Yrs) |
1.008050E-02 |
| Normal-vs-Age(81-100Yrs) |
5.725600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.979040E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.231200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.568600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.600300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.524800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.634600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.054000E-01 |
| Classical-VS-Follicular |
4.045000E-01 |
| Classical-VS-Other |
9.741000E-01 |
| Classical-VS-Normal |
5.982600E-03 |
| Tall-VS-Follicular |
8.077000E-01 |
| Tall-VS-Other |
6.852200E-01 |
| Tall-VS-Normal |
3.963200E-01 |
| Follicular-VS-Other |
7.789600E-01 |
| Follicular-VS-Normal |
1.387630E-01 |
| Other-VS-Normal |
2.681600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.159700E-02 |
| Normal-vs-N1 |
6.621200E-01 |
| N0-vs-N1 |
1.330230E-01 |
|
|
